首页> 外文OA文献 >Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer

【2h】

Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer

机译：RAC1有助于乳腺癌细胞的曲妥珠单抗抗性：RAC1作为治疗抗胸瘤乳腺癌的潜在治疗靶标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Milos Dokmanovic; Dianne S. Hirsch; Yi Shen; Wen Jin Wu;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer. [J] . Dokmanovic M, Hirsch DS, Shen Y, Molecular cancer therapeutics . 2009,第6期

机译：Rac1有助于乳腺癌细胞对曲妥珠单抗的耐药性：Rac1作为抗曲妥珠单抗的潜在治疗靶标。
2. Inactivation of Rac1 reduces Trastuzumab resistance in PTEN deficient and insulin-like growth factor I receptor overexpressing human breast cancer SKBR3 cells. [J] . Zhao Y, Wang Z, Jiang Y, Cancer letters . 2011,第1期

机译：Rac1的失活降低了过表达PTEN和胰岛素样生长因子I受体的人乳腺癌SKBR3细胞中曲妥珠单抗的耐药性。
3. Trastuzumab derived HER2-specific CAR for trastuzumab-resistant breast cancer: CAR T-cells successfully engage target epitopes that are not accessible to antibodies [J] . Szoor A., Toth G., Zsebik B., Human gene therapy . 2019,第11期

机译：Trastuzumab衍生出曲妥珠猴抗乳腺癌的特定于特定的汽车：汽车T细胞成功地接合抗体无法访问的靶表表位
4. Breast Cancer-specific Delivery of Therapeutic microRNA with Novel Breast Cancer-targeting Cell Penetrating Peptide-conjugated Gene Carrier [C] . Hwa Jeong Lee, Ran Namgung, Won Jong Kim, World biomaterials congress . 2012

机译：新型靶向乳腺癌的细胞穿透肽偶联基因载体与治疗性microRNA的乳腺癌特异性递送。
5. Identification of LRP8, CDCA7, and MLK4 as Novel Therapeutic Targets for Cancer Stem Cells in Triple-negative Breast Cancer [D] . Lin, Chang-Ching. 2018

机译：鉴定LRP8，CDCA7和MLK4作为三阴性乳腺癌中癌症干细胞的新疗法靶标
6. The Ratio of RAC1B to RAC1 Expression in Breast Cancer Cell Lines as a Determinant of Epithelial/Mesenchymal Differentiation and Migratory Potential [O] . Caroline Eiden, Hendrik Ungefroren 2021

机译：RAC1B对乳腺癌细胞系RAC1表达的比例作为上皮/间充质分化和迁移潜力的决定因素
7. The Ratio of RAC1B to RAC1 Expression in Breast Cancer Cell Lines as a Determinant of Epithelial/Mesenchymal Differentiation and Migratory Potential [O] . Caroline Eiden, Hendrik Ungefroren 2021

机译：RAC1B对乳腺癌细胞系RAC1表达的比例作为上皮/间充质分化和迁移潜力的决定因素

Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer

著录项

引文网络

相似文献

相关主题

期刊订阅